Adverum Biotechnologies Inc [ADVM] Investment Guide: What You Need to Know
In a filing, Adverum Biotechnologies Inc revealed its Director Lupher, Jr. Mark L. acquired Company’s shares for reported $0.18 million on Feb 07 ’24. In the deal valued at $1.35 per share,130,000 shares were bought. As a result of this transaction, Lupher, Jr. Mark L. now holds 130,000 shares worth roughly $1.56 million. Then, Scopa […]
Short interest on ADVM sees a significant increase on Mar 15, 2024
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Adverum Biotechnologies Inc shares valued at $175,500 were purchased by Lupher, Jr. Mark L. on Feb 07 ’24. At $1.35 per share, Lupher, Jr. Mark L. acquired 130,000 shares. The insider’s holdings grew to […]
ADVM stock rated a Buy by Truist
In a filing, Adverum Biotechnologies Inc revealed its Director Lupher, Jr. Mark L. acquired Company’s shares for reported $0.18 million on Feb 07 ’24. In the deal valued at $1.35 per share,130,000 shares were bought. As a result of this transaction, Lupher, Jr. Mark L. now holds 130,000 shares worth roughly $2.09 million. Then, Scopa […]
Is Adverum Biotechnology, Inc (ADVM) stock Doomed to Fail?
Adverum Biotechnologies, Inc. (ADVM) was subject to a 6.49% drop in share price on April 9th, 2021, now sitting at USD$9.08. Given that they are still in the clinical stages, the full potential of their profitability is still being determined. Nevertheless, ADVM management has time and time again assured investors of their focus on and […]
